CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils

Shock

Volumn 12, Issue 6, 1999, Pages 428-437

  Hauser, Carl J ^a   Fekete, Zoltan ^a   Goodman, Elliot R ^a   Kleinstein, Eric ^a   Livingston, David H ^a   Deitch, Edwin A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CALCIUM; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOTACTIC FACTOR; CXCL1 PROTEIN, HUMAN; GROWTH PROMOTOR; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CALCIUM SIGNALING; DRUG EFFECT; HUMAN; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIGENS, CD; CALCIUM; CALCIUM SIGNALING; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; NEUTROPHILS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0033257921     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199912000-00003     Document Type: Article

References (48)

1. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320:365-76, 1989.
2. Moore EE, Moore FA, Franciose RJ, et al.: The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 37:881-887, 1994.
3. Botha AJ, Moore FA, Moore EE, et al.: Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br J Surg 83:1407-1412, 1996.
4. Hallett MB, Lloyds D: Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today 16:264-268, 1995.
5. Pitman JMd, Thurman GW, Anderson BO, et al.: WEB2170, a specific platelet-activating factor antagonist, attenuates neutrophil priming by human serum after clinical burn injury. J Burn Care Rehabil 12:411-419, 1991.
6. Wozniak A, Betts WH, Murphy GA, Rokicinski M: Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 79:608-615, 1993.
7. Yuo A, Kitagawa S, Kasahara T, et al.: Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 78:2708-2714, 1991.
8. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445, 1998.
9. Hauser CJ, Zhou X, Joshi P, et al.: The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma 42:895-903, 1997.
10. Marty C, Misset B, Tamion F, et al.: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 22:673-679, 1994.
11. Damas P, Canivet JL, de Groote D, et al.: Sepsis and serum cytokine concentrations. Crit Care Med 25:405-412, 1997.
12. Goodman RB, Stricter RM, Martin DP, et al.: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 154:602-11, 1996.
13. McBride WT, Armstrong MA, Gilliland H, McMurray TJ: The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. Cytokine 8:724-729, 1996.
14. Meduri GU, Kohler G, Headley S, et al.: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108:1303-1314, 1995.
15. Partrick DA, Moore FA, Moore EE, et al.: The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 172:425-429, 1996.
16. Stricter RM, Kunkel SL: Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 42:640-651, 1994.
17. Taniguchi H, Kondoh Y, Ikuta N, Takagi K: Diagnosis of acute respiratory distress syndrome: analysis of bronchoalveolar lavage fluid. Nippon Kyobu Shikkan Gakkai Zasshi 33 Supp1:251-256, 1995.
18. Villard J, Dayer-Pastore F, Hamacher J, et al.: GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 152:1549-1554, 1995.
19. Jiang JX, Tian KL, Chen HS, et al.: Plasma cytokines and endotoxin levels in patients with severe injury and their relationship with organ damage. Injury 28:509-513, 1997.
20. Goodman ER, Kleinstein E, Fusco AM, et al.: Role of interleukin 8 in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch Surg 133:1234-1239, 1998.
21. Lee J, Horuk R, Rice GC, et al.: Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283-16287, 1992.
22. L'Heureux GP, Bourgoin S, Jean N, et al.: Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 85:522-531, 1995.
23. Van Damme J, Wuyts A, Froyen G, et al.: Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J Leukoc Biol 62:563-569, 1997.
24. Wuyts A, Proost P, Lenaerts JP, et al.: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 255:67-73, 1998.
25. Wolf M, Delgado MB, Jones SA, et al.: Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur J Immunol 28:164-170, 1998.
26. Chuntharapai A, Kim KJ: Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 155:2587-2594, 1995.
27. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271:20545-20550, 1996.
28. Kleinstein E, Goodman ER, Fusco AM, et al.: CXC chemokine-modulated neutrophil apoptosis: Implications in the treatment of acute respiratory distress syndrome. Surgical Forum XLIX:111-112, 1998.
29. White JR, Lee JM, Young PR, et al.: Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273:10095-10098, 1998.
30. Jones SA, Wolf M, Qin S, et al.: Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93:6682-6686, 1996.
31. Murphy PM: Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34(4):311-8, 1997.
32. Baggiolini M, Moser B, Clark-Lewis I: Interleukin-8 and related chemotactic cytokines. Chest 105:95S-98S, 1994.
33. i signaling in biologic environments. Shock 10:324-328, 1998.
34. Chollet-Martin S, Jourdain B, Gibert C, et al.: Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 154:594-601, 1996.
35. 2+ fluxes in lymphocytes from African Americans and whites. J Hypertens 14:1293-1299, 1996.
36. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985.
37. Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682-5688, 1994.
38. Smith GA, Llaurado JG, Madden JA: Multiexponential and multicompartmental approaches for analysis of tracer washout data from animals. Int J Biomed Comput 10:461-476, 1979.
39. + homeostasis in cultured human skin fibroblasts. J Cell Physiol 131:318-329, 1987.
40. Damaj BB, McColl SR, Neote K, et al.: Diverging signal transduction pathways activated by interleukin 8 (IL-8) and related chemokines in human neutrophils. IL-8 and Gro-alpha differentially stimulate calcium influx through IL-8 receptors A and B. J Biol Chem 271:20540-20544, 1996.
41. Hallett MB, Davies EV, Campbell AK: Oxidase activation in individual neutrophils is dependent on the onset and magnitude of the Ca2+ signal. Cell Calcium 11:655-663, 1990.
42. Krishna MT, Madden J, Teran LM, et al.: Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J 11:1294-1300, 1998.
43. Johnson MCn, Kajikawa O, Goodman RB, et al.: Molecular expression of the alpha-chemokine rabbit GRO in Escherichia coli and characterization of its production by lung cells in vitro and in vivo. J Biol Chem 271: 10853-10858, 1996.
44. Schonbeck U, Brandt E, Petersen F, et al.: IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 154:2375-2383, 1995.
45. Witt DP, Lander AD: Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 4:394-400, 1994.
46. Asagoe K, Yamamoto K, Takahashi A, et al.: Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol 160:4518-4525, 1998.
47. Geiser T, Dewald B, Ehrengruber MU, et al.: The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem 268:15419-15424, 1993.
48. Seely AJE, Swartz DE, Christou NV: Reduction in neutrophil interleukin-8 and C5a receptors following transmigration and in surgical patients with systemic inflammatory response syndrome - Implications for the regulation of neutrophil delivery to the inflammatory microenvironment. Surg Forum XLIX: 104-107, 1998.